215 related articles for article (PubMed ID: 6764629)
1. Reactivity of cold agglutinins with subsets of human lymphocytes of various origins.
Pruzanski W; Armstrong M; Ko H; Norman C; Minta J
Haematologia (Budap); 1982 Dec; 15(4):409-18. PubMed ID: 6764629
[TBL] [Abstract][Full Text] [Related]
2. Study of human T and B lymphocytes with heterologous antisera. I Preparation, specificity and properties of antisera.
Brochier J; Abou-Hamed YA; Gueho JP; Revillard JP
Immunology; 1976 Nov; 31(5):749-58. PubMed ID: 1086826
[TBL] [Abstract][Full Text] [Related]
3. Separation of T lymphocytes from normal individuals and patients with B lymphocyte chronic lymphocytic leukaemia.
Fernandez LA; MacSween JM; Langley GR
Immunology; 1975 Feb; 28(2):231-41. PubMed ID: 1091543
[TBL] [Abstract][Full Text] [Related]
4. Antigen heterogeneity of human B and T lymphocytes.
Rabellino EM; Grey HM; LaForge S; Pirofsky B; Kashiwagi N; Malley A
J Clin Invest; 1976 Feb; 57(2):390-7. PubMed ID: 815274
[TBL] [Abstract][Full Text] [Related]
5. Some effects on leukaemic B lymphocytes of antibodies to defined regions of their surface immunoglobulin.
Stevenson FK; Elliott EV; Stevenson GT
Immunology; 1977 Apr; 32(4):549-57. PubMed ID: 415966
[TBL] [Abstract][Full Text] [Related]
6. Human T cell antigens defined by monoclonal antibodies: the 65,000-dalton antigen of T cells (T65) is also found on chronic lymphocytic leukemia cells bearing surface immunoglobulin.
Royston I; Majda JA; Baird SM; Meserve BL; Griffiths JC
J Immunol; 1980 Aug; 125(2):725-31. PubMed ID: 6993560
[TBL] [Abstract][Full Text] [Related]
7. Restriction in the repertoire of the immunoglobulin light chain subgroup in pathological cold agglutinins with anti-Pr specificity.
Leo A; Kreft H; Hack H; Kempf T; Roelcke D
Vox Sang; 2004 Feb; 86(2):141-7. PubMed ID: 15023185
[TBL] [Abstract][Full Text] [Related]
8. Antibodies to human T lymphocytes in xenoantisera elicited with a new immature T-cell line (Peer).
Schlesinger M; Rabinowitz R; Kertes T; Ravid Z; Goldblum N
Thymus; 1981 Feb; 2(4-5):235-43. PubMed ID: 7015584
[TBL] [Abstract][Full Text] [Related]
9. HLA-DRw alloantigens can be detected on peripheral blood T lymphocytes.
Mann DL; Sharrow SO
J Immunol; 1980 Nov; 125(5):1889-96. PubMed ID: 7000892
[TBL] [Abstract][Full Text] [Related]
10. B lymphocyte specificity of lectins of Cepaea nemoralis and Dolichos biflorus: paradoxical binding of anti-A active lectins to human lymphocyte subclasses.
Zalewski PD; Forbes IJ; Uhlenbruck G; Valente L
Clin Exp Immunol; 1981 May; 44(2):304-14. PubMed ID: 6975674
[TBL] [Abstract][Full Text] [Related]
11. New antigenic determinant (Sa) on human lymphocytes and phagocytes.
Pruzanski W; Armstrong M; Roelcke D
Blut; 1981 Nov; 43(5):307-13. PubMed ID: 6173085
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies against Tmu and B lymphocytes in patients with rheumatoid arthritis.
Meijer CJ; Cnossen J; Lafeber GJ; Damsteeg MJ; Cats A
Clin Exp Immunol; 1982 Feb; 47(2):368-80. PubMed ID: 6978781
[TBL] [Abstract][Full Text] [Related]
13. Surface immunoglobulins are involved in the interaction of protein A with human B cells and in the triggering of B cell proliferation induced by protein A-containing Staphylococcus aureus.
Romagnani S; Giudizi MG; Biagiotti R; Almerigogna F; Maggi E; Del Prete G; Ricci M
J Immunol; 1981 Oct; 127(4):1307-13. PubMed ID: 6974188
[TBL] [Abstract][Full Text] [Related]
14. Strong, specific anti-human leukemia antisera prepared with the use of purified cell membrane antigen.
Negoro S; Seon BK
Cancer Res; 1981 Jul; 41(7):2973-6. PubMed ID: 6972802
[TBL] [Abstract][Full Text] [Related]
15. Significance of T and B lymphocytes in different chronic internal diseases with immune processes.
Mihăilescu E; Micu D; Purice S; Ion V; Miron C; Sighetea E; Constantineanu M; Popescu R
Med Interne; 1976; 14(3):205-10. PubMed ID: 1088212
[TBL] [Abstract][Full Text] [Related]
16. Activated autologous T cells exert an anti-B-cell chronic lymphatic leukemia effect in vitro and in vivo.
Di Ianni M; Moretti L; Terenzi A; Bazzucchi F; Del Papa B; Bazzucchi M; Ciurnelli R; Lucchesi A; Sportoletti P; Rosati E; Marconi PF; Falzetti F; Tabilio A
Cytotherapy; 2009; 11(1):86-96. PubMed ID: 19153855
[TBL] [Abstract][Full Text] [Related]
17. T cells armed with anti-CD3 x anti-CD20 bispecific antibody enhance killing of CD20+ malignant B cells and bypass complement-mediated rituximab resistance in vitro.
Gall JM; Davol PA; Grabert RC; Deaver M; Lum LG
Exp Hematol; 2005 Apr; 33(4):452-9. PubMed ID: 15781336
[TBL] [Abstract][Full Text] [Related]
18. Vdelta1 T lymphocytes from B-CLL patients recognize ULBP3 expressed on leukemic B cells and up-regulated by trans-retinoic acid.
Poggi A; Venturino C; Catellani S; Clavio M; Miglino M; Gobbi M; Steinle A; Ghia P; Stella S; Caligaris-Cappio F; Zocchi MR
Cancer Res; 2004 Dec; 64(24):9172-9. PubMed ID: 15604289
[TBL] [Abstract][Full Text] [Related]
19. Reaction of various human normal and leukemic cells and cells of different cell lines with rabbit antisera prepared against membrane fraction of B and T cell lines.
Koubek K
Neoplasma; 1983; 30(2):187-95. PubMed ID: 6188960
[TBL] [Abstract][Full Text] [Related]
20. Functionally different T lymphocyte subpopulations determined by their sensitivity to complement-dependent cell lysis with the monoclonal antibody 4A.
Morishima Y; Kobayashi M; Yang SY; Collins NH; Hoffmann MK; Dupont B
J Immunol; 1982 Sep; 129(3):1091-8. PubMed ID: 6980917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
